Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3033% below fair value
$10.86−0.13 (-1.18%)
Close on Nov 12, 2026Market cap $913.24MP/E 13.6Yield –
Bioventus cash
Cash and short-term investments held at the end of each period.
Bioventus's cash was $30.71M at Sep 26, 2026. For fiscal 2025 it was $51.24M, up 23.2% from the year before. The highest annual figure on record is $99.21M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.24M | +23.2% |
| FY2024 | Dec 31, 2024 | $41.58M | +12.5% |
| FY2023 | Dec 31, 2023 | $36.96M | +16.1% |
| FY2022 | Dec 31, 2022 | $31.84M | -67.9% |
| FY2021 | Dec 31, 2021 | $99.21M | +14.2% |
| FY2020 | Dec 31, 2020 | $86.84M | +34.6% |
| FY2019 | Dec 31, 2019 | $64.52M | +50.8% |
| FY2018 | Dec 31, 2018 | $42.77M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $30.71M | -27.2% |
| Q2 FY2026 | Jun 27, 2026 | $29.46M | -10.5% |
| Q1 FY2026 | Mar 28, 2026 | $35.85M | +57.2% |
| Q4 FY2025 | Dec 31, 2025 | $51.24M | +23.2% |
| Q3 FY2025 | Sep 27, 2025 | $42.16M | -2.1% |
| Q2 FY2025 | Jun 28, 2025 | $32.91M | +2.9% |
| Q1 FY2025 | Mar 29, 2025 | $22.80M | -9.4% |
| Q4 FY2024 | Dec 31, 2024 | $41.58M | +12.5% |
| Q3 FY2024 | Sep 28, 2024 | $43.07M | +60.6% |
| Q2 FY2024 | Jun 29, 2024 | $31.99M | +8.9% |
| Q1 FY2024 | Mar 30, 2024 | $25.17M | -46.6% |
| Q4 FY2023 | Dec 31, 2023 | $36.96M | +16.1% |
| Q3 FY2023 | Sep 30, 2023 | $26.83M | -22.0% |
| Q2 FY2023 | Jul 1, 2023 | $29.39M | -28.3% |
| Q1 FY2023 | Apr 1, 2023 | $47.10M | -43.0% |
| Q4 FY2022 | Dec 31, 2022 | $31.84M | -67.9% |
| Q3 FY2022 | Oct 1, 2022 | $34.38M | -73.7% |
| Q2 FY2022 | Jul 2, 2022 | $41.00M | -70.3% |
| Q1 FY2022 | Apr 2, 2022 | $82.65M | -36.2% |
| Q4 FY2021 | Dec 31, 2021 | $99.21M | +14.2% |
| Q3 FY2021 | Oct 2, 2021 | $130.92M | +80.6% |
| Q2 FY2021 | Jul 3, 2021 | $138.07M | +9.4% |
| Q1 FY2021 | Apr 3, 2021 | $129.45M | -0.6% |
| Q4 FY2020 | Dec 31, 2020 | $86.84M | +34.6% |
| Q3 FY2020 | Sep 26, 2020 | $72.48M | +69.4% |
| Q2 FY2020 | Jun 27, 2020 | $126.24M | – |
| Q1 FY2020 | Mar 28, 2020 | $130.28M | – |
| Q4 FY2019 | Dec 31, 2019 | $64.52M | – |
| Q4 FY2018 | Dec 31, 2018 | $42.77M | – |
See a number that looks wrong?